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Dear Editor,  
 
we read with great interest the two papers recently published by Torbiarczyk et al. [1] and Springer 
et al. [2] where the authors discuss the role of diagnostic procedures in patients with haemoptysis. 
In the first study the authors evaluated the role of bronchoscopy in identification of bleeding source: 
due to the low visualization rate of the site of bleeding (11%), they suggest a possible overuse of 
bronchoscopy in the diagnosis of haemoptysis, in particular in young patients with a non-massive 
bleeding. Recently an Italian group of study investigated the role of early bronchoscopy (performed 
within 48 hours the onset of the first symptom) in localization of the bleeding site and in diagnosis 
of its cause [3]. They concluded that an early bronchoscopy in the emergency department does not 
improve neither the rate of diagnosis nor the localization of the bleeding. Torbiarzyk et al too, in 
their article discussion, seem to confirm a limited role of bronchoscopy for these two outcomes.  
Springer et al evaluated the efficacy of the bronchial artery embolization (BAE) in patients with 
haemoptysis, describing a high rate of successful procedures [2]. In a paper of Patrucco and 
colleagues, the authors describe the completion of a BAE in a patient with an arteriovenous 
malformation with full resolution of the bleeding [3]. In clinical practice BAE is used to control 
massive haemoptysis, as a bridge to surgical resection or as a definitive therapy, in cases of 
recurrent haemoptysis and in patients who are unfit for surgical procedures [4]. Moreover, in some 
studies BAE is used in case of inconclusive endoscopic intervention [5]. 
 
 
A different topic is the massive haemoptysis that requires an intensive and prompt management. In 
this case the role of fiberoptic and rigid bronchoscopy seems to be pivotal at least for the choice of 
the ipsilateral decubitus to the site of bleeding to protect the healthy lung and to save time for 
different procedures but such important bleedings represent only a small part of the cases admitted 
to the emergency department [6, 7].  
Gavelli and colleagues aimed to improve the management of much more frequent mild-to-moderate 
haemoptysis in their middle-size University hospital by proposing a clinical algorithm with 
different conclusions about the usefulness of fiberoptic endoscopic procedure [8]. It is a multi-step 
approach that provides, in case of recurrent haemoptysis or in case of suspected neoplastic lesion or 
high risk for lung cancer, a computed tomography of the thorax. After the radiologic examination, 
each patient underwent as soon as possible a bronchoscopy with different goals, not only diagnostic 
but also therapeutic. BAE and surgery were reserved respectively to non-neoplastic haemoptysis 
and neoplastic disease or uneffective BAE. Some important aspect of this approach is worthy to be 
underlined: in fact even if recent literature doesn’t seem to suggest an endoscopic evaluation in case 
of a negative computed tomography regarding a diagnostical point of view [9], a bronchoscopy is 
the only procedure able to have a therapeutical role after the definition of the bleeding source, 
giving a chance to a prompt and effective resolution of the cause, in acute and recurrent 
haemoptysis. Infact in high experienced centers with endoscopic oriented pulmonary units, during 
the procedures it is possible to treat some bleeding source with argon plasma coagulation, 
cryotherapy and deploy endobronchial stents [8]. Moreover it’s important to highlight some other 
important usefulness of early bronchoscopy in non-life-threatening haemoptysis: it permits to 
collect a microbiologic and/or cytomorphologic sample of endobronchial secretions or lesions, with 
rapid and specific antibiotic administration, and, finally, it allows to visualize potential bleeding 
causes non detectable with computed tomography (i.e. haemorrhagic tracheobronchitis). Finally, it 
should be always kept in mind that in hemodynamically stable patients, without contraindications, 
bronchoscopy is a safe procedure, providing fundamental results despite low risks [10]. 
In conclusion the role of interventional pulmonology in both the diagnostic and therapeutic aspects 
of haemopthysis is far to be completely defined. Even if we have to differentiate massive from mild 
and moderate bleeding it seems to be reasonable to asses that a bronchoscopy (fiberoptic or rigid) 
can be safely proposed in skilled centers with a wide range of immediate therapeutical 
interventional options, whether pneumological, either radiological or surgical. 
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